3
22
B. Li et al. / Phytochemistry Letters 13 (2015) 319–323
The compounds were isolated by bioassay guiding, and the
the extract (1.3 kg) was extracted with EtOH under reflux
(3 ꢂ1.5 h), and the EtOH-soluble portion was concentrated under
reduced pressure to give a brown solid material (500 g). This
material was applied to a Diaion HP 20 chromatography column
ethanol extract of the aqueous extract of S. angustata showed
effects on lipid-lowering. Additionally, the new compound
sibiskoside exhibited an anti-obesity effect (Ito et al., 2009).
Therefore, compounds from the ethanol extract were preliminarily
evaluated for hypolipidemic activities by assessing their triglycer-
ide content in HepG2 cells (Table 3). Fortunately, compared to the
control group, compounds 1–3 all showed moderate activities
and eluted successively with a gradient of EtOH/H
of the 50% EtOH elution was further subjected to silica gel column
chromatography eluted with CHCl and MeOH in a stepwise
2
O. Then, 25.8 g
3
gradient mode, the eluate of which were monitored by TLC and
similar fractions were combined to afford 10 subfractions. Sub-
fraction 2 (0.36 g) was refractioned on a silica gel column (5.0 cm i.
(
p < 0.01) in HepG2 cells, which were in accordance with our
previously reported results. The structural analysis declared that
these compounds were all esters, possibly leading to their similar
activities, and further investigations continue in our laboratory.
d., 57 cm, 360–420 mesh) eluted gradiently with CHCl
refractions 21–25 were finally purified on a silica gel column eluted
gradiently with C /(Me) CO (9:1, 8:2, 7:3). Compound 1 was
obtained from the C /(Me) CO (8:2) eluate (25 mg, recrystallized
in hexane). Subfraction 4 (2.8 g) was dissolved in methanol and
repartitioned to a silica gel column eluted gradiently with CHCl
3
/MeOH, and
H
6 6
2
3
. Experimental
6
H
6
2
3
.1. General experimental procedures
3
/
MeOH (20:1–1:1) to obtain 30 fractions. Fraction 15 (0.7 g) was
Optical rotations were measured on a JASCO P-2000 polarimeter
subjected to silica gel column chromatography (5.0 cm i.d., 100 cm,
using MeOH as the solvent. CD spectra were obtained on a JASCO J-
15 spectrometer. UV spectra were obtained on JASCO
V650 spectrophotometer. IR spectra were recorded on a Nicolet
700 FT-IR spectrometer by the microscope transmission method.
NMR spectra were obtained on an INOVA-500 MHz NMR spectrom-
3
200–300 mesh) eluted gradiently with CHCl /MeOH, from which
eluate 4 was precipitated and recrystallized by methanol to afford
3 (60 mg). 70 g of the 20% EtOH elution was subjected to silica gel
8
a
5
column chromatography (2000 g) and eluted with CHCl
O to give 15 fractions (A–O). Fraction B (15.0 g) was fractionated
on an ODS column (50 m, 400 g) eluted with a MeOH/H O solvent
3
/MeOH/
H
2
1
13
eter operating at 500 MHz for H and at 125 MHz for C. Chemical
shifts are given in (ppm) with solvent (DMSO-d or CD COCD
m
2
d
6
3
3
)
system (5:95 ! 50:50) to give 10 subfractions. Subfraction B-10
(0.7 g) was purified by preparative HPLC and eluted with 13% CAN
at a flow rate of 7 ml/min (210 nm) to obtain 2 (20 mg).
peaks used as references. GC was conducted using an Agilent 7890A
instrument (Agilent). ESI–MS spectra were measured on an Agilent
1100 SeriesLC/MSDiontrapmassspectrometer.HRESIMSdatawere
recorded on an Autospec Ultima-TOF mass spectrometer. Analytical
HPLC was run on an Agilent 1100 series instrument with a UV/DAD
3.4. Alkaloid hydrolysis and sugar analysis of compounds 3
ꢃ
detector using a YMC column (RP-C18, 4.6 ꢂ 250 mm, 5
m
m).
Compound 3 (20 mg) was refluxed in 2 M KOH (0.5 ml) at 100 C
Preparative HPLC was performed on a Shimadzu LC-6AD instru-
ment with an SPD-10A detector using a YMC-Pack ODS-A column
for 1 h and neutralized with HCl. The neutralization solution was
then partitioned by polyamide column chromatography and eluted
with MeOH to obtain caffeic acid (6 mg) and D-glucitol (5 mg), the
NMR spectral data of which match the reference values.
(
20 ꢂ 250 mm, 5
AmershamPharmaciaBiotechABFactory, Sweden. ODS(45–70
MerckKGaA,Darmstadt,Germany),DiaionHP20macroporousresin
Mitsuboshi Chemical Industries, Tokyo, Japan), and silica gel (200–
00 mesh, Qingdao Marine Chemical Inc., PR China) were used for
m
m). The Sephadex LH-20 was obtained from
m
m,
(
3
3.5. Hypolipidemic activity assays
column chromatography. TLC was performed on glass pre-coated
with silica gel GF254 (200–300 mesh, Qingdao Marine Chemical Inc.,
PR, China). Spots were visualized under UV light or byspraying with
The hypolipidemic activities of compounds 1–3 were assayed as
described previously (Wang et al., 2013).
1
0% H
.2. Plant Materials
S.angustata (Rehd.) Hand.-Mazz was collected in the Sichuan
2
SO
4
in 95% EtOH, followed by heating.
3.5.1. 3-(2-hydroxyl-4-methyl-3-pentenyl)furan-5H-2-one (1)
ꢃ
25
Colorless needles (Hexane); mp 68–70 C, [
CHCl ); UV (MeOH) max (log ) 284 (1.53), 308 (1.36) nm; IR (KBr)
max 3424 (OH),1726 (CO) cm ; HNMR (CD
D
a] -21.5 (c 1.30,
3
3
l
e
1 1
ꢁ
n
3
OD, 400 MHz) d: 5.19
(1H, dd, J = 6.4, 1.6 Hz, H-7), 4.29 (1H, ddd, J = 8.8, 8.0, 2.2 Hz, H-6),
3.90 (1H, ddd, J = 12.0, 8.4, 3.6 Hz, H-1a), 3.69 (1H, m, H-1b), 2.91
(1H, m, H-3), 1.96, 1.89 (each 1H, m, H-2), 2.00, 1.69 (each 1H, m, H-
province, China in 2002 and identified by professor Wang Tianzhi
in West China School of Pharmacy, Sichuan University, China.
5
), 1.73 (3H, d, J = 1.2 Hz, CH
3
-9), 1.70 (3H, d, J = 1.2 Hz, CH
3
-10);
+
+
3.3. Extraction and Isolation
EIMS (+) m/z 184 [M] (20), 169 [M–CH
84.1112 (calc’d for C10 , 184.1100).
3
] (100); HREIMS (+) m/z
1
16 3
H O
The air-dried and powdered aerial portion of S. angustata
(
25.5 kg) was extracted with 250 L of boiling water (3 ꢂ1 h), and
3.5.2. 3-(2-hydroxyl-4-methyl-3-pentenyl)furan-2-en-2(5H)-one (2)
2
5
the decoction was then spray-dried to yield 3.0 kg of extract. Part of
Colorless oil; [
07 (2.11), 308 (1.15) nm; IR (KBr)
a
]
D
-16.5(c 1.0, CHCl
3
); UV (MeOH)
l
max (log
e
)
;
ꢁ
1
2
nmax 3419 (OH), 1747 (CO) cm
1
Table 3
HNMR (CD
1H, dd, J = 8.5, 1.5, H-7), 4.80 (2H, d, J = 1.5 Hz, H-1), 4.70(1H, m,
OH), 4.40 (1H, m, H-6), 2.36 (1H, ddd, J = 14.5, 7.5,1.5 Hz, H-5a), 2.22
1H, ddd, J = 14.5, 7.5, 1.5 Hz, H-5b), 1.63 (3H, d, J = 1.0 Hz, CH -9),
3
1.56 (3H, d, J = 1.0 Hz, CH -10); ESIMS (+) m/z 205 [M + Na] (53),
3
OD, 400 MHz) d: 7.44 (1H, dd, J = 2.0, 1.0 Hz, H-2), 5.10
Hypolipdaemic effects of compounds 1–3 on triglyceride content in HepG2.
(
Group
Concentration
Results
(
3
model
simvastatin
1
2
3
0.3410 ꢄ 0.0113
0.1799 ꢄ 0.0109
ꢁ
ꢁ
ꢁ
ꢁ
5
5
5
5
**
*
+
10
10
10
10
M
M
M
M
+
+
0.2185 ꢄ 0.0072
387 [2 M + Na] (100); HRESIMS (+) m/z 182.0942 [M] (calc'd for
, 182.0943).
*
0.2130 ꢄ 0.0183
0.2221 ꢄ 0.0133
10 14 3
C H O
*
Data were expressed as mean ꢄ S.E.
3
.5.3. 1,6-sorbitol-O-dicaffeic acid ester (3)
Light yellow powder; UV (MeOH) max (log
2.06) nm; IR (KBr) max 3386 (OH), 1686 (CO), 1642 (CO),
*
p < 0.05.
l
e) 284 (3.32), 308
*
*
p < 0.01 vs control group.
(
n